These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18364763)

  • 21. Cardiovascular disease risk profile tools and New Zealand--absolutely the best way forward.
    Wells S; Riddell T; Jackson R
    J Prim Health Care; 2010 Jun; 2(2):168-9. PubMed ID: 20695051
    [No Abstract]   [Full Text] [Related]  

  • 22. Ethnic differences in cardiovascular disease risk factors and diabetes status for Pacific ethnic groups and Europeans in the Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
    Sundborn G; Metcalf PA; Gentles D; Scragg RK; Schaaf D; Dyall L; Black P; Jackson R
    N Z Med J; 2008 Sep; 121(1281):28-39. PubMed ID: 18797481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Audiometric pattern as a predictor of cardiovascular status: development of a model for assessment of risk.
    Friedland DR; Cederberg C; Tarima S
    Laryngoscope; 2009 Mar; 119(3):473-86. PubMed ID: 19235737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients' responsiveness to a decision support tool for primary prevention of cardiovascular diseases in primary care.
    van Steenkiste B; van der Weijden TM; Stoffers JH; GROL RP
    Patient Educ Couns; 2008 Jul; 72(1):63-70. PubMed ID: 18395393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice.
    van der Weijden T; Bos LB; Koelewijn-van Loon MS
    Curr Opin Cardiol; 2008 Sep; 23(5):471-6. PubMed ID: 18670259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary heart disease and cardiovascular risk factors among people aged 25-65 years, as seen in Romanian primary healthcare.
    Bunescu DM; Stoffers HE; van den Akker M; Jan Dinant G
    Eur J Gen Pract; 2008; 14(2):56-64. PubMed ID: 18720274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of a patient's personal health history on assessments of future risk of coronary heart disease.
    Mainous AG; Everett CJ; Player MS; King DE; Diaz VA
    J Am Board Fam Med; 2008; 21(5):408-13. PubMed ID: 18772295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status--PREDICT CVD-9.
    Kerr AJ; McLachlan A; Furness S; Broad J; Riddell T; Jackson R; Wells S
    N Z Med J; 2008 Nov; 121(1285):20-33. PubMed ID: 19079434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Improved medical documentation for the management of patients with cardiovascular pathology].
    Satmari VV; Gribenko VV
    Vrach Delo; 1982 Jun; (6):115-7. PubMed ID: 6981255
    [No Abstract]   [Full Text] [Related]  

  • 30. PHARMAC and cardiovascular health in New Zealand.
    Moodie P
    N Z Med J; 2008 Mar; 121(1270):102-5. PubMed ID: 18364762
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk in cardiovascular disease. Joint British societies recommend their computer program for risk calculations.
    Durrington PN
    BMJ; 2000 Jul; 321(7254):174-5. PubMed ID: 10950540
    [No Abstract]   [Full Text] [Related]  

  • 32. NAFLD and cardiovascular risk: direct evidence for the tale of two ages.
    Lonardo A; Loria P
    Am J Gastroenterol; 2009 Jul; 104(7):1851-2. PubMed ID: 19574981
    [No Abstract]   [Full Text] [Related]  

  • 33. [Integration of a new risk marker into cardiovascular prevention, using coronary calcium as an example].
    Möhlenkamp S; Lehmann N; Moebus S; Schmermund A; Jöckel KH; Erbel R;
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2023-6. PubMed ID: 19777421
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics and cardiovascular risk of new cases of type 2 diabetes in Otago, New Zealand, 1998-2004.
    Coppell K; Williams S; Anderson K; Lamb C; Mann J
    Diabetes Res Clin Pract; 2008 Dec; 82(3):396-401. PubMed ID: 18990463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing methods for assessing cardiovascular risk.
    Mancia G
    J Hypertens; 2009 Dec; 27(12):2342-3. PubMed ID: 19920731
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cardiovascular disease in patients with inflammatory arthritis in primary care: a cross-sectional observation.
    Peters MJ; Nielen MM; Raterman HG; Verheij RA; Schellevis FG; Nurmohamed MT
    J Rheumatol; 2009 Sep; 36(9):1866-8. PubMed ID: 19648308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of six polymorphisms to cardiovascular risk in a Dutch high-risk primary care population: the HIPPOCRATES project.
    Plat AW; Stoffers HE; Klungel OH; van Schayck CP; de Leeuw PW; Soomers FL; Schiffers PM; Kester AD; Kroon AA
    J Hum Hypertens; 2009 Oct; 23(10):659-67. PubMed ID: 19242491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using multiple frames in health surveys.
    Metcalf P; Scott A
    Stat Med; 2009 May; 28(10):1512-23. PubMed ID: 19266543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.